CAR-T: Management of Cytokine Release Syndrome and Neurotoxicity

Tox Check Chimeric Antigen Receptor T-Cell (CAR-T)Подробнее

Multiple Myeloma Treatment: Induction, CAR T, Managing Side Effects and Maintaining Quality of LifeПодробнее

Managing toxicities associated with bispecific T-cell engaging therapies in patients with myelomaПодробнее

Transformative potential of CAR-T cell therapy: current challenges and future DirectionsПодробнее

What are the management strategies for CRS and ICANS in MM?Подробнее

Episode 176: Oncologic Emergencies 101: Cytokine Release SyndromeПодробнее

Episode 267: Side-Effect Management for CAR T-Cell Therapy for Hematologic MalignanciesПодробнее

Module 2: Toxicity Assessment and Management | Early & Late Side EffectsПодробнее

Chimeric Antigen Receptor T-Cell Therapy, From Approval to Practice, Managing Side EffectsПодробнее

What are the strategies to manage toxicities with CAR T-cell therapies?Подробнее

Let’s Take a BiTE Out of CRS and Neurotoxicity - B. Kikani - 20231018Подробнее

Comparing BMT and CAR-T therapy: learnings for patient care and managementПодробнее

Neuro Lecture: Neurotoxicities of CAR T cell and ICI with Dr Bianca SantomassoПодробнее

Coordinating Better Outcomes in Multiple MyelomaПодробнее

Siltuximab for the management of CAR-T toxicities: a multicenter retrospective studyПодробнее

Management of CAR-T Toxicities: CRS, Neurological, Cytopenias, InfectionПодробнее

Managing Acute Toxicities of CAR T-cell TherapyПодробнее

Management of Immuno-Toxicity in Patients Receiving CAR T-Cell Therapy– Dr.ClaireRoddie(May26-27'23)Подробнее

Identifying and managing patients at high risk of developing toxicities following CAR-T therapyПодробнее

NCCN Patient Webinar: CAR T-Cell Therapy for Lymphoma and Side EffectsПодробнее